Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2024-03-14 AGM Information
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by IntroMedic regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict and confirms compliance with regulatory disclosure requirements. Since it is a specific regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2024-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Intromedic. It outlines the date, location, and agenda items (financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the meeting and request their participation/votes, which aligns with the Proxy Solicitation & Information Statement category.
2024-02-01 Korean
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Delisting Announcement Classification · 100% confidence The document is a regulatory filing from a Korean company (IntroMedic) detailing financial results and specifically addressing 'Management of Administrative Issues', 'Formal Delisting', and 'Substantive Review of Listing Eligibility' due to financial losses exceeding 50% of equity. This is a standard regulatory disclosure (DART filing) regarding financial status and listing risks, which falls under the 'Regulatory Filings' category as it is a mandatory disclosure of material financial events.
2024-02-01 Korean
기타경영사항(자율공시)(만기전 취득 제12회 무기명식 이권부 무보증 사모 전환사채 소각 결정의 건)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Intromedic regarding the cancellation of previously acquired convertible bonds (debt instruments). This falls under capital structure changes and financing updates. Since it specifically details the cancellation of debt securities to enhance shareholder value, it fits best under the 'Capital/Financing Update' category.
2024-02-01 Korean
기타시장안내(상장적격성 실질심사 사유추가 우려 안내)
Delisting Announcement Classification · 100% confidence The document is a regulatory notice issued by the Korea Exchange regarding Intromedic. It informs the market about the potential for additional grounds for a listing eligibility review due to financial losses. As this is a regulatory announcement regarding market status and listing compliance rather than a financial report or a specific corporate action like a dividend or share buyback, it falls under the general regulatory filing category.
2024-02-01 Korean
[기재정정]전환청구권행사(제12회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the company 'IntroMedic' regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the updated listing date. This type of filing relates to changes in capital structure and share issuance resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2024-01-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.